Plasmacytoid urothelial carcinoma, a chemosensitive cancer with poor prognosis, and peritoneal carcinomatosis

Journal of Urology

Volumn 189, Issue 5, 2013, Pages 1656-1661

  Dayyani, Farshid ^a   Czerniak, Bogdan A ^a   Sircar, Kanishka ^a   Munsell, Mark F ^a   Millikan, Randall E ^a   Dinney, Colin P ^a   Siefker Radtke, Arlene O ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

carcinoma; mortality; rare diseases; urinary bladder; urothelium

Indexed keywords

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CARCINOMATOUS PERITONITIS; CHEMOSENSITIVITY; CLINICAL ARTICLE; FEMALE; HUMAN; MALE; OVERALL SURVIVAL; PERITONEUM METASTASIS; PLASMACYTOID UROTHELIAL CARCINOMA; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RETROSPECTIVE STUDY; TRANSITIONAL CELL CARCINOMA; TRANSURETHRAL RESECTION; TREATMENT OUTCOME;

EID: 84876281755     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2012.11.084     Document Type: Article

References (17)

1. R. Montironi, A. Lopez-Beltran The 2004 WHO classification of bladder tumors: a summary and commentary Int J Surg Pathol 13 2005 143
2. K.T. Mai, P.C. Park, H.M. Yazdi Plasmacytoid urothelial carcinoma of the urinary bladder report of seven new cases Eur Urol 50 2006 1111
3. B. Keck, R. Stoehr, S. Wach The plasmacytoid carcinoma of the bladder - rare variant of aggressive urothelial carcinoma Int J Cancer 129 2011 346
4. T. Kohno, M. Kitamura, H. Akai Plasmacytoid urothelial carcinoma of the bladder Int J Urol 13 2006 485
5. A. Lopez-Beltran, M.J. Requena, R. Montironi Plasmacytoid urothelial carcinoma of the bladder Hum Pathol 40 2009 1023
6. P. Nigwekar, P. Tamboli, M.B. Amin Plasmacytoid urothelial carcinoma: detailed analysis of morphology with clinicopathologic correlation in 17 cases Am J Surg Pathol 33 2009 417
7. M.R. Raspollini, I. Sardi, L. Giunti Plasmacytoid urothelial carcinoma of the urinary bladder: clinicopathologic, immunohistochemical, ultrastructural, and molecular analysis of a case series Hum Pathol 42 2011 1149
8. J.Y. Ro, S.S. Shen, H.I. Lee Plasmacytoid transitional cell carcinoma of urinary bladder: a clinicopathologic study of 9 cases Am J Surg Pathol 32 2008 752
9. E. Kaplan, P. Meier Nonparametric estimation from incomplete observations J Am Stat Assoc 53 1958 457
10. D. Cox Regression models and life tables (with discussion) J Roy Stat Soc B 34 1972 187
11. A.O. Siefker-Radtke, C.P. Dinney, N.A. Abrahams Evidence supporting preoperative chemotherapy for small cell carcinoma of the bladder: a retrospective review of the M.D. Anderson cancer experience J Urol 172 2004 481
12. A.O. Siefker-Radtke, A.M. Kamat, H.B. Grossman Phase II clinical trial of neoadjuvant alternating doublet chemotherapy with ifosfamide/doxorubicin and etoposide/cisplatin in small-cell urothelial cancer J Clin Oncol 27 2009 2592
13. D.J. McConkey, S. Lee, W. Choi Molecular genetics of bladder cancer: emerging mechanisms of tumor initiation and progression Urol Oncol 28 2010 429
14. H.M. Fritsche, M. Burger, S. Denzinger Plasmacytoid urothelial carcinoma of the bladder: histological and clinical features of 5 cases J Urol 180 2008 1923
15. A.O. Siefker-Radtke, C.P. Dinney, Y. Shen A phase 2 clinical trial of sequential neoadjuvant chemotherapy with ifosfamide, doxorubicin, and gemcitabine followed by cisplatin, gemcitabine, and ifosfamide in locally advanced urothelial cancer: final results Cancer 119 2012 540
16. J.P. Stein, G. Lieskovsky, R. Cote Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients J Clin Oncol 19 2001 666
17. O. Topalak, U. Saygili, M. Soyturk Serum, pleural effusion, and ascites CA-125 levels in ovarian cancer and nonovarian benign and malignant diseases: a comparative study Gynecol Oncol 85 2002 108